推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Cancer Cell International 期刊收藏夹

2025年6月最新IF影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER CELL INT最新评论:30 jan 2025投稿,当天with editor;08 feb 2025 first reviewer(s) invited;03 apr 2025 revision requested;18 may ... (2025-05-19)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
近期推荐:
IF2.6,科学、技术与医学跨学科期刊征稿中
SCI论文AI润色+人工QC服务
同行专家帮助选刊
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Cancer Cell International期刊基本信息Hello,您是该期刊的第165379位访客

基本信息 登录收藏
期刊名字Cancer Cell InternationalCancer Cell International

CANCER CELL INT
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.1
73人评分
我要评分

声誉
7.7

影响力
6.2

速度
8.2

期刊ISSN1475-2867
蝌蝌APP,让您与同行交流更轻松
立即下载
2024-2025最新影响因子
(数据来源于搜索引擎)
6 点击查看影响因子趋势图
实时影响因子 截止2025年5月19日:5.98
2024-2025自引率1.70%点击查看自引率趋势图
五年影响因子5.3
JCI期刊引文指标 1.08
h-index 47
CiteScore
2025年最新版
CiteScoreSJRSNIPCiteScore排名
10.901.5001.097
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Genetics
Q133 / 348
大类:Biochemistry, Genetics and Molecular Biology
小类:Oncology
Q152 / 415
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q146 / 233

期刊简介
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.

The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors.

Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.
期刊官方网站http://cancerci.biomedcentral.com
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://submission.nature.com/new-submission/12935/3
作者指南网址http://cancerci.biomedcentral.com/submission-guidelines
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Cell International的语言要求,还能让Cancer Cell International编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Cell International编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(6篇)
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( GBP2190; USD2990; EUR2490; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:cancer cell biology、cell culture
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
出版商BioMed Central
涉及的研究方向ONCOLOGY-
出版国家或地区ENGLAND
出版语言English
出版周期Irregular
出版年份2001
年文章数 406点击查看年文章数趋势图
Gold OA文章占比99.91%
研究类文章占比:
文章 ÷(文章 + 综述)
76.11%
WOS期刊SCI分区
2024-2025年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ155/326
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ172/326
中国科学院《国际期刊预警
名单(试行)》名单
2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:预警等级:中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2025年3月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区3区3区
ONCOLOGY
肿瘤学
1区3区3区
中国科学院SCI期刊分区
2023年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区2区2区
ONCOLOGY
肿瘤学
3区4区3区
中国科学院SCI期刊分区
2022年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区4区
ONCOLOGY
肿瘤学
2区3区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1475-2867%5BISSN%5D
平均审稿速度网友分享经验:
平均1月
平均录用比例网友分享经验:
约50%
版面费/APC文章处理费信息
文章处理费:需要( GBP2190; USD2990; EUR2490; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Cancer Cell International顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(6篇)
提交文稿
期刊常用信息链接
同领域相关期刊 Cancer Cell International期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Cancer Cell International中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Cancer Cell International上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE740781
    BIOMATERIALS613550
    BIOMEDICINE & PHARMACOTHERAPY606638
    Frontiers in Pharmacology572852
    COMPUTERS IN BIOLOGY AND MEDICINE567167
    Frontiers in Immunology559692
    JOURNAL OF ETHNOPHARMACOLOGY559555
    Frontiers in Oncology500439
    COLLOIDS AND SURFACES B-BIOINTERFACES470366
    PHYTOMEDICINE463518
  •  

    Cancer Cell International Cancer Cell International
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer

    Author: Zhong, Xingyu; Yang, Yuxuan; He, Haodong; Xiong, Yifan; Zhong, Mingliang; Wang, Shaogang; Xia, Qidong
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03788-w
        PubMed      DOI
    2.Taurochenodeoxycholic acid suppresses the progression of glioblastoma via HMGCS1/HMGCR/GPX4 signaling pathway in vitro and in vivo

    Author: Xue, Xiumin; He, Ziwan; Liu, Furui; Wang, Qian; Chen, Zhichao; Lin, Lin; Chen, Danni; Yuan, Yinfeng; Huang, Zhihui; Wang, Yongjie
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03782-2
        PubMed      DOI
    3.Identifying PSIP1 as a critical R-loop regulator in osteosarcoma via machine-learning and multi-omics analysis

    Author: Nie, Jiangbo; Wang, Shijiang; Zhong, Yanxin; Yang, Feng; Liu, Jiaming; Liu, Zhili
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03775-1
        PubMed      DOI
    4.Hsa_circ_0072088 promotes non-small cell lung cancer progression through modulating miR-1270/TOP2A axis

    Author: Li, Sixuan; Cui, Zhigang; Gao, Min; Shan, Yanan; Ren, Yihong; Zhao, Yuxin; Wang, Di; Meng, Tingyu; Liu, Hongxu; Yin, Zhihua
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03749-3
        PubMed      DOI
    5.Single-cell RNA sequencing reveals cellular and molecular heterogeneity in extensive-stage small cell lung cancer with different chemotherapy responses

    Author: Gu, Zhan; Heng, Yongqing; Fan, Rui; Luo, Jie; Ju, Lixia
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03785-z
        PubMed      DOI
    6.Identification and exploration of key genes associated with radioresistance in lung adenocarcinoma

    Author: Wang, Ying; Shang, Yangyang; Hua, Mingyu; Wang, Yidi; Hui, Beina; Hu, Weibin; Zhu, Mengke; Zhang, Xiaozhi; Li, Jing
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03783-1
        PubMed      DOI
    7.Intratumoral microbiota for hepatocellular carcinoma: from preclinical mechanisms to clinical cancer treatment

    Author: Chen, Muhua; Bie, Lei
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03745-7
        PubMed      DOI
    8.Efficacy and safety of modified bleomycin administration with EP chemotherapy in adult male patients with germ cell tumors: a retrospective study

    Author: Shu, Ditian; Huang, Riqing; Chen, Meiting; Li, Haifeng; An, Xin; Xue, Cong; Hu, Anqi; Zhou, Fangjian; Yao, Kai; Liu, Zhuowei; Shi, Yanxia
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03774-2
        PubMed      DOI
    9.A Chinese prospective cohort research developed and validated a risk prediction model for patients with cervical cancer

    Author: Yuan, Li; Wen, Baogang; Li, Xiuying; Lei, Haike; Zou, Dongling; Zhou, Qi
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03744-8
        PubMed      DOI
    10.Identification and validation of platinum resistance signature in gastric cancer

    Author: Yan, Wenjing; Zhu, Nan; Zhao, Yupeng; Sang, Qingqing; Li, Jianfang; Liu, Bingya; Yang, Zhongyin; Yu, Beiqin
    Journal: CANCER CELL INTERNATIONAL. 2025; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12935-025-03777-z
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    同分区等级的其他期刊名称 h-index CiteScore
    HemaSphere07.20
    COMMUNICATIONS OF THE ACM18914.30
    Wiley Interdisciplinary Reviews-Data Mining and Knowledge Discovery3121.70
    Journal of High Energy Astrophysics119.20
    Business & Information Systems Engineering018.60
    Business & Information Systems Engineering018.60
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY2114.80
    Battery Energy011.00
    Progress in Energy020.10
    CLINICAL NUCLEAR MEDICINE533.00
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共732


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2025 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室